Xencor
Patents, Design & Utilities
Last updated:
List of all Xencor patents 117 in total
| Status | Patent |
|---|---|
Application | Utility: BISPECIFIC ANTIBODIES THAT BIND CD123 AND CD3 Filling date: 8 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: OPTIMIZED Fc VARIANTS Filling date: 8 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: Fc VARIANTS WITH ALTERED BINDING TO FcRn Filling date: 8 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: Fc VARIANTS WITH ALTERED BINDING TO FcRn Filling date: 8 Sep 2025 Issue date: 22 Apr 2021 |
Grant | Utility: Heterodimeric antibodies that bind fibroblast activation protein Filling date: 8 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors Filling date: 8 Sep 2025 Issue date: 20 Apr 2021 |
Application | Utility: HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS Filling date: 8 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: COMPLEMENT COMPONENT C5 ANTIBODIES Filling date: 8 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: HETERODIMERIC IgG-LIKE BISPECIFIC ANTIBODIES Filling date: 8 Sep 2025 Issue date: 8 Apr 2021 |
Grant | Utility: Optimized anti-CD3 variable regions Filling date: 8 Sep 2025 Issue date: 6 Apr 2021 |
Application | Utility: BISPECIFIC ANTIBODIES THAT BIND CD20 AND CD3 Filling date: 8 Sep 2025 Issue date: 1 Apr 2021 |
Application | Utility: BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND CHECKPOINT RECEPTORS Filling date: 8 Sep 2025 Issue date: 1 Apr 2021 |
Application | Utility: DOSING OF A BISPECIFIC ANTIBODY THAT BINDS PD1 AND CTLA4 Filling date: 8 Sep 2025 Issue date: 18 Mar 2021 |
Grant | Utility: Heterodimeric antibodies that bind CD3 and tumor antigens Filling date: 8 Sep 2025 Issue date: 9 Feb 2021 |
Application | Utility: METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS Filling date: 8 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS Filling date: 8 Sep 2025 Issue date: 14 Jan 2021 |
Grant | Utility: Heterodimeric antibodies that bind CD3 and tumor antigens Filling date: 8 Sep 2025 Issue date: 12 Jan 2021 |
Grant | Utility: Bispecific antibodies that bind to CD38 and CD3 Filling date: 8 Sep 2025 Issue date: 8 Dec 2020 |
Grant | Utility: Heterodimeric proteins Filling date: 8 Sep 2025 Issue date: 8 Dec 2020 |
Grant | Utility: Heterodimeric human IgG1 polypeptides with isoelectric point modifications Filling date: 8 Sep 2025 Issue date: 1 Dec 2020 |
Application | Utility: MODULATION OF T CELLS WITH BISPECIFIC ANTIBODIES AND FC FUSIONS Filling date: 8 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS Filling date: 8 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: OPTIMIZED ANTIBODIES THAT TARGET CD19 Filling date: 8 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: HETERODIMERIC ANTIBODIES THAT BIND ENPP3 AND CD3 Filling date: 8 Sep 2025 Issue date: 8 Oct 2020 |
Grant | Utility: Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors Filling date: 8 Sep 2025 Issue date: 6 Oct 2020 |
Grant | Utility: Bispecific checkpoint inhibitor antibodies Filling date: 8 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: Complement component C5 antibodies Filling date: 8 Sep 2025 Issue date: 25 Aug 2020 |
Application | Utility: Fc VARIANTS WITH ALTERED BINDING TO FcRn Filling date: 8 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: Fc VARIANTS WITH ALTERED BINDING TO FcRn Filling date: 8 Sep 2025 Issue date: 13 Aug 2020 |
Grant | Utility: Heterodimeric proteins Filling date: 8 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Heterodimeric proteins Filling date: 8 Sep 2025 Issue date: 11 Aug 2020 |
Application | Utility: IL-12 HETERODIMERIC FC-FUSION PROTEINS Filling date: 8 Sep 2025 Issue date: 9 Jul 2020 |
Application | Utility: HETERODIMERIC ANTIBODIES THAT BIND CD3 AND PSMA Filling date: 8 Sep 2025 Issue date: 9 Jul 2020 |
Application | Utility: HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38 Filling date: 8 Sep 2025 Issue date: 25 Jun 2020 |
Application | Utility: METHODS OF TREATING NEUROLOGICAL DISEASES Filling date: 8 Sep 2025 Issue date: 4 Jun 2020 |
Application | Utility: HETERODIMERIC ANTIBODIES THAT BIND FIBROBLAST ACTIVATION PROTEIN Filling date: 8 Sep 2025 Issue date: 28 May 2020 |
Application | Utility: PD-1 TARGETED IL-15/IL-15RALPHA FC FUSION PROTEINS AND USES IN COMBINATION THERAPIES THEREOF Filling date: 8 Sep 2025 Issue date: 7 May 2020 |
Application | Utility: BISPECIFIC HETERODIMERIC FUSION PROTEINS CONTAINING IL-15 - IL-15Ralpha Fc-FUSION PROTEINS AND IMMUNE CHECKPOINT ANTIBODY FRAGMENTS Filling date: 8 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR SIMULTANEOUS BIVALENT AND MONOVALENT CO-ENGAGEMENT OF ANTIGENS Filling date: 8 Sep 2025 Issue date: 23 Apr 2020 |
Grant | Utility: Optimized antibodies that target CD19 Filling date: 8 Sep 2025 Issue date: 21 Apr 2020 |
Grant | Utility: Fc variants with increased affinity for Fc.gamma.RIIc Filling date: 8 Sep 2025 Issue date: 10 Mar 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS Filling date: 8 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: HETERODIMERIC PROTEINS Filling date: 8 Sep 2025 Issue date: 13 Feb 2020 |
Grant | Utility: Anti-CD39 antibodies and uses thereof Filling date: 8 Sep 2025 Issue date: 11 Feb 2020 |
Application | Utility: IL15/IL15Ralpha HETERODIMERIC Fc-FUSION PROTEINS Filling date: 8 Sep 2025 Issue date: 6 Feb 2020 |
Grant | Utility: Bispecific heterodimeric fusion proteins containing IL-15-IL-15R.alpha. Fc-fusion proteins and PD-1 antibody fragments Filling date: 8 Sep 2025 Issue date: 4 Feb 2020 |
Grant | Utility: Targeting regulatory T cells with heterodimeric proteins Filling date: 8 Sep 2025 Issue date: 28 Jan 2020 |
Grant | Utility: Heterodimeric antibodies that bind CD3 and CD38 Filling date: 8 Sep 2025 Issue date: 7 Jan 2020 |
Grant | Utility: Targeting regulatory T cells with heterodimeric proteins Filling date: 8 Sep 2025 Issue date: 31 Dec 2019 |
Application | Utility: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES Filling date: 8 Sep 2025 Issue date: 26 Dec 2019 |
Showing 50 to 100 of 117 patents.